Abstract
TPS10575Background: Acute lymphoblastic leukemia (ALL) relapse in children and adults is associated with poor prognosis. Venetoclax (VEN) is a potent, highly selective BCL-2 inhibitor, and navitocl...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
